CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BioThrust's ComfyCell bioreactor provides a novel solution for the industrial cultivation of sensitive stem and immune cells, addressing the challenges of high shear forces and environmental fluctuations. This technology aims to enhance the scalability and efficiency of cell therapies for various medical conditions, ma…
Stem and immune cell therapies are transforming modern medicine, offering new treatments for conditions like cancer, neurodegenerative diseases, and autoimmune disorders.
Leveraging cells such as induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), Natural Killer (NK) cells, and T-cells, these therapies hold the potential to address diseases affecting hundreds of millions worldwide.
However, the inability to scale the production of these cells presents a major bottleneck in mak…
BIOTHRUST GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
